Céline Bonnefous

1.9k total citations
18 papers, 615 citations indexed

About

Céline Bonnefous is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Céline Bonnefous has authored 18 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 4 papers in Physiology. Recurrent topics in Céline Bonnefous's work include Neuroscience and Neuropharmacology Research (6 papers), Receptor Mechanisms and Signaling (5 papers) and Pharmacological Receptor Mechanisms and Effects (4 papers). Céline Bonnefous is often cited by papers focused on Neuroscience and Neuropharmacology Research (6 papers), Receptor Mechanisms and Signaling (5 papers) and Pharmacological Receptor Mechanisms and Effects (4 papers). Céline Bonnefous collaborates with scholars based in United States and Sweden. Céline Bonnefous's co-authors include Randolph P. Thummel, Theodore M. Kamenecka, A. Chouai, Blake A. Rowe, Hervé Schaffhauser, John H. Hutchinson, Jean‐Michel Vernier, Lorrie P. Daggett, Jeffrey Roppe and Nicholas D. Smith and has published in prestigious journals such as Chemical Communications, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Céline Bonnefous

18 papers receiving 592 citations

Peers

Céline Bonnefous
Duncan Shaw United Kingdom
Russell A. Lewthwaite United Kingdom
Eyup Akgün United States
Zhizhou Yue United States
Kristine Prendergast United States
Kwang H. Ahn United States
Céline Bonnefous
Citations per year, relative to Céline Bonnefous Céline Bonnefous (= 1×) peers Barbara Wenzel

Countries citing papers authored by Céline Bonnefous

Since Specialization
Citations

This map shows the geographic impact of Céline Bonnefous's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Céline Bonnefous with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Céline Bonnefous more than expected).

Fields of papers citing papers by Céline Bonnefous

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Céline Bonnefous. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Céline Bonnefous. The network helps show where Céline Bonnefous may publish in the future.

Co-authorship network of co-authors of Céline Bonnefous

This figure shows the co-authorship network connecting the top 25 collaborators of Céline Bonnefous. A scholar is included among the top collaborators of Céline Bonnefous based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Céline Bonnefous. Céline Bonnefous is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Govek, Steven P., Céline Bonnefous, Johnny Nagasawa, et al.. (2018). Selective estrogen receptor degraders with novel structural motifs induce regression in a tamoxifen-resistant breast cancer xenograft. Bioorganic & Medicinal Chemistry Letters. 29(3). 367–372. 7 indexed citations
2.
Govek, Steven P., Johnny Nagasawa, Karensa Douglas, et al.. (2015). Optimization of an indazole series of selective estrogen receptor degraders: Tumor regression in a tamoxifen-resistant breast cancer xenograft. Bioorganic & Medicinal Chemistry Letters. 25(22). 5163–5167. 36 indexed citations
3.
Durón, Sergio G., Andrew B. Lindstrom, Céline Bonnefous, et al.. (2011). Heteroaromatic-aminomethyl quinolones: Potent and selective iNOS inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(2). 1237–1241. 7 indexed citations
5.
Symons, Kent T., Mark E. Massari, Jeffrey Roppe, et al.. (2009). KLYP956 Is a Non-Imidazole-Based Orally Active Inhibitor of Nitric-Oxide Synthase Dimerization. Molecular Pharmacology. 76(1). 153–162. 11 indexed citations
7.
Rowe, Blake A., Hervé Schaffhauser, Laura S. Lubbers, et al.. (2008). Transposition of Three Amino Acids Transforms the Human Metabotropic Glutamate Receptor (mGluR)-3-Positive Allosteric Modulation Site to mGluR2, and Additional Characterization of the mGluR2-Positive Allosteric Modulation Site. Journal of Pharmacology and Experimental Therapeutics. 326(1). 240–251. 38 indexed citations
8.
Payne, Joseph E., Céline Bonnefous, Christian A. Hassig, et al.. (2008). Identification of KD5170: A novel mercaptoketone-based histone deacetylase inhibitor. Bioorganic & Medicinal Chemistry Letters. 18(23). 6093–6096. 21 indexed citations
9.
Wash, Paul L., Timothy Z. Hoffman, Brandon M. Wiley, et al.. (2008). α-Mercaptoketone based histone deacetylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(24). 6482–6485. 7 indexed citations
10.
Abrahamsson, Maria, et al.. (2007). Six-Membered Ring Chelate Complexes of Ru(II):  Structural and Photophysical Effects. Inorganic Chemistry. 46(24). 10354–10364. 54 indexed citations
11.
Hamill, Terence G., Stephen M. Krause, Christine Ryan, et al.. (2005). Synthesis, characterization, and first successful monkey imaging studies of metabotropic glutamate receptor subtype 5 (mGluR5) PET radiotracers. Synapse. 56(4). 205–216. 124 indexed citations
12.
Govek, Steven P., Céline Bonnefous, John H. Hutchinson, et al.. (2005). Benzazoles as allosteric potentiators of metabotropic glutamate receptor 2 (mGluR2): Efficacy in an animal model for schizophrenia. Bioorganic & Medicinal Chemistry Letters. 15(18). 4068–4072. 35 indexed citations
13.
Bonnefous, Céline, Jean‐Michel Vernier, John H. Hutchinson, et al.. (2005). Biphenyl-indanones: Allosteric potentiators of the metabotropic glutamate subtype 2 receptor. Bioorganic & Medicinal Chemistry Letters. 15(19). 4354–4358. 36 indexed citations
14.
Kamenecka, Theodore M., Céline Bonnefous, Steven P. Govek, et al.. (2005). Dipyridyl amines: Potent metabotropic glutamate subtype 5 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 15(19). 4350–4353. 7 indexed citations
15.
Bonnefous, Céline, et al.. (2004). Dipyridyl amides: potent metabotropic glutamate subtype 5 (mGlu5) receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 15(4). 1197–1200. 25 indexed citations
16.
Hu, Yizhen, et al.. (2004). A luminescent Pt(ii) complex with a terpyridine-like ligand involving a six-membered chelate ring. Dalton Transactions. 354–354. 34 indexed citations
17.
Bonnefous, Céline, A. Chouai, & Randolph P. Thummel. (2001). Cyclometalated Complexes of Ru(II) with 2-Aryl Derivatives of Quinoline and 1,10-Phenanthroline. Inorganic Chemistry. 40(23). 5851–5859. 44 indexed citations
18.
Bonnefous, Céline, et al.. (1999). Self assembly of a diphenanthrolinylpyrene-bridged CuI trimer. Chemical Communications. 1243–1244. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026